APA (7th ed.) Citation

Lin, Y., Zhao, Y., Chen, M., Li, Z., Liu, Q., Chen, J., . . . Zhang, Q. (2023). CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-10974-4

Chicago Style (17th ed.) Citation

Lin, Yihua, et al. "CYD0281, a Bcl-2 BH4 Domain Antagonist, Inhibits Tumor Angiogenesis and Breast Cancer Tumor Growth." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-10974-4.

MLA (9th ed.) Citation

Lin, Yihua, et al. "CYD0281, a Bcl-2 BH4 Domain Antagonist, Inhibits Tumor Angiogenesis and Breast Cancer Tumor Growth." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-10974-4.